Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice Scandinavia 247 Nov 19, 2019 17.50 +2.64   
 2cureX AB 2CUREX Nov 19, 2019 13.65 -1.80   
 A3 Allmänna IT- och Telekomakt ATRE Nov 19, 2019 16.40 +3.80   
 AAC Clyde Space AB (publ) AAC Nov 19, 2019 5.34 -0.19   
 AAK AAK Nov 19, 2019 180.00 +0.06   
 ABB ABB Nov 19, 2019 211.20 -0.47   
 Abelco Investment Group ABIG Nov 19, 2019 0.12 -5.65   
 ABG Sundal Collier Holding ASCO 0.00 0.00   
 Absolent Group ABSO Nov 19, 2019 395.00 +1.28   
 Absolicon ABSL Nov 19, 2019 134.50 -3.58   
 AcadeMedia ACAD Nov 19, 2019 51.00 -1.16   
 Acarix ACARIX Nov 19, 2019 1.92 +6.69   
 Acconeer ACCON Nov 19, 2019 19.96 +1.53   
 Acosense ACOS Nov 19, 2019 2.24 +1.82   
 AcouSort ACOU Nov 19, 2019 10.40 -2.35   
 Acrinova ACRI Nov 19, 2019 22.00 -2.65   
 Actic Group ATIC Nov 19, 2019 21.70 -0.46   
 Active Biotech ACTI Nov 19, 2019 2.62 -4.38   
 AcuCort ACUC Nov 19, 2019 2.57 +5.33   
 Adapteo ADAPT Nov 19, 2019 118.00 +2.61   
 AdCityMedia ACM Nov 19, 2019 164.00 +37.82   
 AdderaCare ADDERA Nov 19, 2019 5.22 +2.35   
 AddLife B ALIFB Nov 19, 2019 236.00 -0.42   
 Addnode Group B ANODB Nov 19, 2019 171.50 -1.44   
 Addtech B ADDTB Nov 19, 2019 262.00 0.00   
 ADDvise Group A ADDVA Nov 19, 2019 1.08 0.00   
 ADDvise Group B ADDVB Nov 19, 2019 0.69 -11.54   
 Adevinta B ADEBO Nov 19, 2019 100.60 0.00   
 Advanced Stabilized Technologi ASTGB Nov 19, 2019 3.23 -1.22   
 Advenica ADVE Nov 19, 2019 2.98 -0.33   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK